Does anti-inflammatory action of amiodarone explain the high efficacy in patients with heart failure?

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 622-623

  Nakaya, Haruaki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; C REACTIVE PROTEIN; DISOPYRAMIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; QUINIDINE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG INHIBITION; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; NONHUMAN; SUPRAVENTRICULAR TACHYCARDIA;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; CHEMOKINE CCL2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65649128117     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0038     Document Type: Editorial

References (11)

1. The Cardiac Arrhythmia Suppression Trial Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412.
2. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al for The Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and symptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
3. Doval HC, Nul DR, Grancelli HO, Bortman GR, Cruiel R. Randomized trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344: 493-498.
4. Mann DL, Young JB. Basic mechanisms in congestive heart failure: Recognitizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904. (Pubitemid 24088479)
5. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Asa H, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998; 97: 1136-1143. (Pubitemid 28152886)
6. Hirasawa Y, Nakagomi A, Kobayashi Y, Katoh T, Mizuno K. Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia. Circ J 2009; 73: 639-646.
7. Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S. Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: A possible mechanism for its effect in heart failure. Circulation 1997; 96: 1386-1389. (Pubitemid 27375326)
8. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891. (Pubitemid 33139098)
9. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: Insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003; 107: 1440-1446. (Pubitemid 36350745)
10. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res 1997; 35: 13-29. (Pubitemid 27374736)
11. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation 1999; 100: 690-692. (Pubitemid 29383636)